Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CYTL1 | Human | 1-naphthyl isothiocyanate | decreases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CYTL1 mRNA | CTD | PMID:30723492 | CYTL1 | Human | 17beta-estradiol | decreases expression | ISO | Cytl1 (Mus musculus) | 6480464 | Estradiol results in decreased expression of CYTL1 mRNA | CTD | PMID:19484750 | CYTL1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CYTL1 mRNA | CTD | PMID:25878060 | CYTL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYTL1 mRNA | CTD | PMID:21998131 | CYTL1 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:26705709 | CYTL1 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CYTL1 mRNA | CTD | PMID:21179406 | CYTL1 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Cytl1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CYTL1 mRNA | CTD | PMID:20188158 | CYTL1 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of CYTL1 mRNA | CTD | PMID:27685785 | CYTL1 | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cytl1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CYTL1 mRNA | CTD | PMID:28973697 | CYTL1 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of CYTL1 mRNA | CTD | PMID:24780913 | CYTL1 | Human | acrylamide | increases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of CYTL1 mRNA | CTD | PMID:28959563 | CYTL1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CYTL1 mRNA | CTD | PMID:15894607 more ... | CYTL1 | Human | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of CYTL1 mRNA | CTD | PMID:15894607 | CYTL1 | Human | amphetamine | increases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of CYTL1 mRNA | CTD | PMID:30779732 | CYTL1 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of CYTL1 mRNA | CTD | PMID:15070760 more ... | CYTL1 | Human | arsenous acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CYTL1 mRNA and Arsenic Trioxide inhibits the reaction [SP1 protein binds to CYTL1 promoter] | CTD | PMID:15761015 and PMID:15894607 | CYTL1 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CYTL1 3' UTR more ... | CTD | PMID:27901495 and PMID:30157460 | CYTL1 | Human | benzo[b]fluoranthene | decreases expression | ISO | Cytl1 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of CYTL1 mRNA | CTD | PMID:26377693 | CYTL1 | Human | bisphenol A | affects expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CYTL1 mRNA | CTD | PMID:25181051 | CYTL1 | Human | bisphenol A | decreases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CYTL1 mRNA | CTD | PMID:30816183 and PMID:32528016 | CYTL1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CYTL1 mRNA | CTD | PMID:27685785 | CYTL1 | Human | C60 fullerene | affects expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | fullerene C60 affects the expression of CYTL1 mRNA | CTD | PMID:19167457 | CYTL1 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of CYTL1 mRNA | CTD | PMID:25979313 | CYTL1 | Human | carbon nanotube | decreases expression | ISO | Cytl1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CYTL1 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CYTL1 mRNA | CTD | PMID:19320972 | CYTL1 | Human | copper atom | increases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | Copper results in increased expression of CYTL1 mRNA | CTD | PMID:30556269 | CYTL1 | Human | copper(0) | increases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | Copper results in increased expression of CYTL1 mRNA | CTD | PMID:30556269 | CYTL1 | Human | deoxynivalenol | decreases expression | EXP | | 6480464 | deoxynivalenol results in decreased expression of CYTL1 mRNA | CTD | PMID:31863870 | CYTL1 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of CYTL1 mRNA | CTD | PMID:15070760 more ... | CYTL1 | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CYTL1 mRNA and Arsenic Trioxide inhibits the reaction [SP1 protein binds to CYTL1 promoter] | CTD | PMID:15761015 and PMID:15894607 | CYTL1 | Human | diuron | increases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | Diuron results in increased expression of CYTL1 mRNA | CTD | PMID:21551480 | CYTL1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CYTL1 | Human | folic acid | decreases expression | ISO | Cytl1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CYTL1 mRNA | CTD | PMID:25629700 | CYTL1 | Human | fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of CYTL1 promoter | CTD | PMID:22847954 | CYTL1 | Human | furan | decreases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | furan results in decreased expression of CYTL1 mRNA | CTD | PMID:25539665 | CYTL1 | Human | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of CYTL1 mRNA | CTD | PMID:15761015 | CYTL1 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of CYTL1 mRNA | CTD | PMID:24768652 and PMID:25583101 | CYTL1 | Human | ozone | increases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | Ozone results in increased expression of CYTL1 mRNA | CTD | PMID:28623178 | CYTL1 | Human | ozone | multiple interactions | ISO | Cytl1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CYTL1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYTL1 mRNA | CTD | PMID:34911549 | CYTL1 | Human | paraquat | decreases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of CYTL1 mRNA | CTD | PMID:32680482 | CYTL1 | Human | parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of CYTL1 promoter | CTD | PMID:22847954 | CYTL1 | Human | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of CYTL1 mRNA | CTD | PMID:25812627 | CYTL1 | Human | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of CYTL1 mRNA | CTD | PMID:25812627 | CYTL1 | Human | reactive oxygen species | affects expression | EXP | | 6480464 | Reactive Oxygen Species affects the expression of CYTL1 mRNA | CTD | PMID:15761015 | CYTL1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CYTL1 | Human | serpentine asbestos | decreases expression | ISO | Cytl1 (Mus musculus) | 6480464 | Asbestos and Serpentine results in decreased expression of CYTL1 mRNA | CTD | PMID:21514415 | CYTL1 | Human | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of CYTL1 mRNA | CTD | PMID:31863870 | CYTL1 | Human | terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of CYTL1 promoter | CTD | PMID:22847954 | CYTL1 | Human | titanium dioxide | affects expression | ISO | Cytl1 (Mus musculus) | 6480464 | titanium dioxide affects the expression of CYTL1 mRNA | CTD | PMID:23557971 | CYTL1 | Human | titanium dioxide | decreases expression | ISO | Cytl1 (Rattus norvegicus) | 6480464 | titanium dioxide results in decreased expression of CYTL1 mRNA | CTD | PMID:30012374 | CYTL1 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of CYTL1 mRNA | CTD | PMID:24935251 and PMID:26272509 | CYTL1 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYTL1 mRNA | CTD | PMID:27188386 | CYTL1 | Human | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of CYTL1 mRNA | CTD | PMID:30510588 | CYTL1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CYTL1 mRNA | CTD | PMID:25979313 | CYTL1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CYTL1 mRNA | CTD | PMID:23179753 more ... | CYTL1 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYTL1 mRNA | CTD | PMID:27188386 | CYTL1 | Human | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYTL1 mRNA | CTD | PMID:27188386 | CYTL1 | Human | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of CYTL1 mRNA | CTD | PMID:26272509 | |